Lipo Lab South Africa
IGF-1 LR3 - OXYGENS LAB
IGF-1 LR3 - OXYGENS LAB
Couldn't load pickup availability
IGF‑1 LR3 from OXYGENS LAB is a modified growth factor supplied as a powder for reconstitution. It is intended for adult athletes and experienced users seeking a performance‑orientated peptide under professional supervision. This page summarises what the product is, how it’s typically handled, and safety considerations — it is not medical advice.
At a glance
- Intended users: adults experienced with peptide use; consult a clinician before use
- Form: powder for reconstitution (see packaging for concentration and vial size)
- Primary purpose: a long‑acting IGF‑1 analogue used in performance contexts
- Texture / scent: powder for injection — no topical texture or fragrance
- Cruelty free: see product label or brand information
What it is
Name | Form | Notes |
---|---|---|
IGF‑1 LR3 (OXYGENS LAB) | Lyophilised peptide (powder) | Reconstitute with bacteriostatic water as directed on the label; follow clinical guidance for injection and dosing |
How to use
- Reconstitution: follow the manufacturer label. Use bacteriostatic water and aseptic technique when preparing.
- Administration: this product is for parenteral use only; typical practice is a single daily injection as prescribed by a healthcare professional. Rotate injection sites and use sterile supplies.
- Monitoring: because peptides can affect blood glucose and other systems, monitor symptoms and consult a clinician if you are diabetic or taking other medicines.
- Medical advice: do not self‑prescribe — discuss dosing, cycles and interactions with a qualified practitioner.
Why it works
- IGF‑1 analogue: IGF‑1 LR3 is a modified form of the body’s IGF‑1 signalling molecule and is designed to remain active longer than native IGF‑1.
- Cell signalling: it engages IGF‑1 receptors involved in nutrient uptake and tissue repair processes at a cellular level.
- Extended activity: chemical modifications reduce rapid binding to carrier proteins, which prolongs time in circulation compared with unmodified IGF‑1.
What to expect
- Individual responses vary. Some users report changes in recovery and muscle fullness within a few weeks; larger or more noticeable outcomes typically require consistent, supervised use over several weeks.
- Any unexpected pain, persistent swelling, signs of infection at an injection site, or symptoms of low blood sugar should be assessed by a clinician promptly.
Good to know
- Potential side effects reported include low blood sugar (hypoglycaemia), joint discomfort, water retention and nausea. Stop use and seek medical advice if you experience severe or persistent reactions.
- Avoid use if pregnant, breastfeeding, under 18, or if you have untreated medical conditions unless cleared by a healthcare professional.
- Do not mix with other hormones or medications without medical supervision; interactions can affect safety and blood glucose control.
Ingredients (INCI)
See packaging for the full INCI and concentration details.
Storage & care
- Store refrigerated between 2–8°C when instructed by the label.
- After reconstitution, follow the manufacturer’s guidance for on‑board shelf life; commonly a limited period is advised.
- Protect from direct light, avoid freezing, and keep out of reach of children.
Shipping & returns
Fast, tracked delivery nationwide in South Africa (2–5 business days). For returns and cold‑chain considerations, follow the store’s returns policy and contact customer service if you have concerns about transit.
If you have questions about this product or how it fits your plans, please contact our customer support for guidance before purchasing.
Share
